Personal profile
Research interests
I am interested in clinical based outcomes research with a particular interest in gynecologic malignancies, chemotherapy, and surgical interventions
Clinical interests
Surgical and medical management of gynecologic malignancies, clinical treatment trials, minimally invasive surgery (robotic and laparoscopic), integrative care
Fingerprint
Dive into the research topics where Carolyn McCourt is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress (Mol. Cancer Res., (2026), 24, (198))
Mullen, M., Lomonosova, E., Toboni, M. D., Oplt, A., Cybulla, E., Blachut, B., Zhao, P., Noia, H., Wilke, D., Rankin, E. B., Kuroki, L. M., Hagemann, A. R., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Mutch, D. G., Powell, M., Mosammaparast, N., Vindigni, A. & Fuh, K., Mar 2026, In: Molecular Cancer Research. 24, 3, p. 198 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
ACR Appropriateness Criteria® Ovarian Cancer Screening: 2024 Update
Expert Panel on GYN and OB Imaging, May 2025, In: Journal of the American College of Radiology. 22, 5, p. S359-S371Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Amplifying SGO'S voice: The impact of the Society of Gynecologic Oncology (SGO) clinical practice committee publications in Gynecologic Oncology
Huang, M., McCourt, C., Powell, M. A. & Lu, K. H., Nov 2025, In: Gynecologic oncology. 202, p. A1-A2Research output: Contribution to journal › Editorial
-
A Plain Language Summary of “Dostarlimab for primary advanced or recurrent endometrial cancer”
Mirza, M. R., Chase, D. M., Slomovitz, B. M., Christensen, R. D. P., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Hanker, L. C., Stuckey, A., Boere, I., Gold, M. A., Auranen, A., Pothuri, B., Cibula, D., McCourt, C., Raspagliesi, F. & Shahin, M. S. & 11 others, , 2025, In: Future Oncology. 21, 2, p. 151-168 18 p.Research output: Contribution to journal › Article › peer-review
-
A plain language summary publication of patients’ survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Powell, M. A., Bjørge, L., Willmott, L., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Gropp-Meier, M., Stuckey, A., Boere, I., Gold, M. A., Segev, Y., Gill, S. E., Gennigens, C., Sebastianelli, A., Shahin, M. S., Pothuri, B. & Monk, B. J. & 11 others, , Jan 1 2025, In: Therapeutic Advances in Medical Oncology. 17, 17588359251342241.Research output: Contribution to journal › Review article › peer-review
Open Access